OncoPrecision
OncoPrecision is an oncology therapeutics company developing precision medicines to give patients transformational options — guided by their biology, defined by their lives.
About OncoPrecision
Recent Funding lists OncoPrecision under Health and bio. It went through IndieBio (IndieBio SF 11). It was founded by Tarek Zaki, Candelaria Llorens, Gastón Soria and 1 other.
Funding rounds
- X account created
- IndieBio SF 11
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
TZ
Tarek Zaki Co-Founder CEOsource: oncoprecision.bioCL
Candelaria Llorens Co-Founder Head of Operationssource: oncoprecision.bioGS
Gastón Soria Co-Founder CSOsource: oncoprecision.bioGG
Gerardo Gatti Co-Founder Head of Clinical Researchsource: oncoprecision.bio
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
OncoPrecision: questions and answers
- Who invested in OncoPrecision?
- Investors on record for OncoPrecision: IndieBio.
- Who founded OncoPrecision?
- OncoPrecision was founded by Tarek Zaki (Co-Founder CEO), Candelaria Llorens (Co-Founder Head of Operations), Gastón Soria (Co-Founder CSO) and Gerardo Gatti (Co-Founder Head of Clinical Research).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oncoprecision (get a free API key).